Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.38 -0.13 (-2.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Return on Sales [ROS] (2021 - 2026)

Updated

Verrica Pharmaceuticals (VRCA) reported Return on Sales [ROS] of -223.42% for Q2 2026, down 235.31 percentage points from 11.89% a year earlier and down 30.01 percentage points from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Verrica Pharmaceuticals' Return on Sales [ROS] came in at -93.59%, up 118.47 percentage points year-over-year; for FY2025, it came in at -34.25%, up 837.00 percentage points from FY2024.

  • Return on Sales [ROS] has a four-year change of +223.32 percentage points (FY2021 to FY2025).
  • By year, Return on Sales [ROS] came in at -871.25% in FY2024 (+412.10 pp), -1283.35% in FY2023 (-1047.57 pp), -235.78% in FY2022 (+21.78 pp) and -257.57% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q1 2025.
  • Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +277.10 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q1 2024 (a gain of 18673.34 percentage points); the low point was Q1 2023 (a drop of 17440.20 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -193.41% (Q1 2026), -141.24% (Q4 2025) and 11.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Verrica Pharmaceuticals 75.24 Mn -7.80 Mn - -223.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -223.42%
Mar 31, 2026 -193.41%
Dec 31, 2025 -141.24%
Sep 30, 2025 11.34%
Jun 30, 2025 11.89%
Mar 31, 2025 -236.41%
Dec 31, 2024 -3,316.86%
Sep 30, 2024 -1,162.49%
Jun 30, 2024 -293.72%
Mar 31, 2024 -486.12%
Dec 31, 2023 -1,163.78%
Sep 30, 2023 -819.92%
Jun 30, 2023 -6,382.42%
Mar 31, 2023 -19,159.46%
Dec 31, 2022 -9,133.82%
Sep 30, 2022 17.41%
Jun 30, 2022 -4,262.15%
Mar 31, 2022 -1,719.26%
Dec 31, 2021 -257.58%
Mar 31, 2021 0.50%
API Access

Verrica Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEY